INAB   $0.277  -4.45% Market Closed

IN8bio, Inc.
Total Cash 10.22M
totalCashPerShare 0.218
EBITDA -30.63M
Total Debt 5.90M
quickRatio 2.147
currentRatio 2.665
Total Revenue
debtToEquity 43.301
Revenue/Share
ROA -0.77639997
ROE -1.80452
grossProfits
freeCashflow -12.41M
operatingCashflow -24.57M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 12.95M
forwardPE -1.1123333
floatShares 25.92M
sharesOutstanding 72.55M
sharesShort 147.36K
sharesShortPriorMonth 188.85K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.22%
heldPercentInstitutions 0.46%
Short Ratio help_outline 0.42%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 0.293
Price To Book help_outline 1.14
earningsQuarterlyGrowth
netIncomeToCommon -31.96M
trailingEps -0.82%
forwardEps -0.30%
enterpriseToEbitda -0.42
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.16 3Q 2024
institutionsCount 29
lastUpdated Nov. 7, 2024, 3:28 a.m.